Wendy Lund, CEO of GCI Health since 2010, is leaving the BCW unit to take the chief communications officer job at Organon & Co.
Kristin Cahill, North America president, will succeed Lund on Jan. 1. The 17-year GCI veteran was New York market leader prior to rising to the presidency in 2015. Cahill will report to Donna Imperato, BCW CEO.
“Kristin has spent her entire career in the healthcare industry, providing strategic and creative counsel to clients, recruiting and retaining the industry’s top talent and fostering a very strong culture,” said Imperato in a statement.
She credited Cahill for serving as a key member of the leadership team that “catapulted the agency from a boutique into a global powerhouse.”
Organon, which has more than 10K employees, is the spin-off of Merck & Co.’s women’s health, contraceptive and fertility businesses.
It also has a line of dermatology, pain, respiratory and cardiovascular products.